Holger Aulbach

Thermo Fisher Scientific (Germany)

Papers

1

Total Citations

12

H-Index

1

About

Holger Aulbach is a pioneering researcher in the field of automated cell therapy manufacturing, with a focus on robotic systems and scalable bioprocessing. His most-cited work, "Development of a robotic cluster for automated and scalable cell therapy manufacturing" (2024), has already garnered 12 citations, highlighting its immediate impact on advancing clinical-grade cell production. Aulbach’s major contributions lie in designing robotic clusters that integrate precision automation with bioreactor control, enabling reproducible, high-throughput manufacturing of cell therapies—a critical step toward making personalized treatments accessible. His research bridges robotics, bioengineering, and process optimization, addressing key bottlenecks in cell therapy scalability. Notably, his work has been recognized for its potential to reduce human error and contamination risks in Good Manufacturing Practice (GMP) environments. By demonstrating that automated clusters can match or exceed manual processes in yield and quality, Aulbach is shaping the future of regenerative medicine. His achievements underscore a commitment to translating lab-scale innovations into industrial realities, making him a key figure in the next generation of biomanufacturing.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Development of a robotic cluster for automated and scalable cell therapy manufacturing
12 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 30
🏛 Institutions: Thermo Fisher Scientific (Germany)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago